These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 21056739)
41. Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment. Raje N; Snyder BL; Hill DA; Streicher JL; Sullivan KE Ann Allergy Asthma Immunol; 2018 May; 120(5):537-538.e1. PubMed ID: 29563054 [No Abstract] [Full Text] [Related]
42. Use of immunoglobulins in adults in a university hospital: a retrospective study. Farber CM; Van der Biest-Cardinal C Acta Clin Belg; 2011; 66(6):416-8. PubMed ID: 22338302 [TBL] [Abstract][Full Text] [Related]
47. [Therapy recommendations for the use of intravenously applicable immunoglobulins]. Marschner JP; Rietbrock N Med Klin (Munich); 1996 Mar; 91(3):141-7. PubMed ID: 8628200 [No Abstract] [Full Text] [Related]
51. The role of intravenous immunoglobulins in pediatric diseases. Ramasubramanian KV; Kumar A; Kabra SK; Seth V Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123 [No Abstract] [Full Text] [Related]
52. Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions. Matsumoto S; Kobayashi N; Gohya N Eur J Pediatr; 1981 May; 136(2):167-71. PubMed ID: 6164555 [No Abstract] [Full Text] [Related]
53. Established and new uses of intravenous immunoglobulin. Cunningham-Rundles C Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751 [TBL] [Abstract][Full Text] [Related]
54. Subcutaneous immunoglobulin replacement therapy: the European experience. Chapel H; Gardulf A Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):623-9. PubMed ID: 24126615 [TBL] [Abstract][Full Text] [Related]